Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 12:47:55 28/02/2017 HKT 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.64M 2.47M 2.26M 4.26M 295M 4.31M 29.22M 11.36M 148M 11.56M 11.31M 490M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.11M 2.91M 2.66M 5.02M 347M 5.07M 34.42M 13.38M 174M 13.62M 13.33M 577M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.75%+4.56%+3.28%+24.99% 51.21B
+1.01%-0.20%+471.68%+564.93% 45.35B
+0.16%+7.88%+36.14%+20.76% 42.84B
-0.66%+2.61%+18.59%+87.04% 42.29B
+0.88%-3.48%+17.20%+53.83% 32.15B
-0.12%+3.84%+33.73%+145.25% 17.31B
-0.53%+1.84% - - 16.55B
+0.49%+5.68%+10.31%+31.79% 14.84B
+1.15%+4.17%+84.49%+50.33% 14.25B
Average +10.31%+12.90%+84.43%+122.36% 27.68B
Weighted average by Cap. +0.37%+3.07%+101.40%+141.80%

Financials

2017 2018
Net sales 16.01K 13.72K 12.84K 11.74K 22.14K 1.53M 22.38K 152K 59.06K 770K 60.11K 58.81K 2.55M 124 106.27 99.41 90.89 171.52 11.87K 173.34 1.18K 457.42 5.96K 465.58 455.5 19.73K
Net income -481K -412K -386K -353K -665K -46.05M -672K -4.56M -1.77M -23.12M -1.81M -1.77M -76.51M -976K -836K -782K -715K -1.35M -93.41M -1.36M -9.26M -3.6M -46.91M -3.66M -3.58M -155M
Net Debt 497K 426K 398K 364K 687K 47.56M 694K 4.71M 1.83M 23.88M 1.87M 1.82M 79.02M 548K 470K 440K 402K 758K 52.5M 767K 5.2M 2.02M 26.36M 2.06M 2.01M 87.23M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-